home / stock / frln / frln quote
Last: | $6.48 |
---|---|
Change Percent: | 0.0% |
Open: | $6.49 |
Close: | $6.48 |
High: | $6.49 |
Low: | $6.48 |
Volume: | 5,663 |
Last Trade Date Time: | 02/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.48 | $6.49 | $6.48 | $6.49 | $6.48 | 5,663 | 02-19-2024 |
$6.48 | $6.49 | $6.48 | $6.49 | $6.48 | 5,663 | 02-16-2024 |
$6.48 | $6.48 | $6.48 | $6.49 | $6.48 | 15,285 | 02-15-2024 |
$6.47 | $6.49 | $6.47 | $6.49 | $6.47 | 4,776 | 02-14-2024 |
$6.49 | $6.435 | $6.49 | $6.49 | $6.435 | 32,752 | 02-13-2024 |
$6.45 | $6.3952 | $6.45 | $6.48 | $6.3952 | 51,215 | 02-12-2024 |
$6.43 | $6.43 | $6.43 | $6.43 | $6.39 | 3,070 | 02-09-2024 |
$6.43 | $6.39 | $6.43 | $6.43 | $6.39 | 2,185 | 02-08-2024 |
$6.4 | $6.43 | $6.4 | $6.43 | $6.4 | 5,842 | 02-07-2024 |
$6.44 | $6.42 | $6.44 | $6.44 | $6.42 | 5,695 | 02-06-2024 |
$6.44 | $6.42 | $6.44 | $6.45 | $6.42 | 3,134 | 02-05-2024 |
$6.43 | $6.42 | $6.43 | $6.44 | $6.42 | 5,722 | 02-02-2024 |
$6.42 | $6.42 | $6.42 | $6.44 | $6.42 | 2,284 | 02-01-2024 |
$6.44 | $6.42 | $6.44 | $6.44 | $6.42 | 2,644 | 01-31-2024 |
$6.44 | $6.44 | $6.44 | $6.45 | $6.42 | 9,631 | 01-30-2024 |
$6.4 | $6.39 | $6.4 | $6.4344 | $6.39 | 5,250 | 01-29-2024 |
$6.41 | $6.42 | $6.41 | $6.42 | $6.4 | 4,447 | 01-26-2024 |
$6.405 | $6.415 | $6.405 | $6.42 | $6.4 | 1,688 | 01-25-2024 |
$6.39 | $6.36 | $6.39 | $6.44 | $6.36 | 19,465 | 01-24-2024 |
$6.41 | $6.41 | $6.41 | $6.41 | $6.37 | 2,491 | 01-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
Freeline Therapeutics Holdings plc Company Name:
FRLN Stock Symbol:
NASDAQ Market:
Freeline Therapeutics Holdings plc Website:
Late-breaking oral presentation on results from Phase 1/2 study of FLT201 in Gaucher disease Poster presentation to highlight Freeline’s GBA1 Parkinson’s disease research program LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Freeline Therapeutics today announced the...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
Please find enclosed the presentation of Frontline plc´s fourth quarter 2023 results to be held on the webcast / conference call 29 February, 2024 at 15:00 CET. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act ...